Given the central involvement of T cells in antitumor immunity, factors that influence PD-1/PD-L1 expression can shape the immune microenvironment by altering T cell quantity and function, thereby affecting the immunotherapeutic response in cervical cancer. This evidence concerns the gene CD274 and cervical carcinoma.